Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease

BACKGROUND: The benefit of low‐density lipoprotein cholesterol (LDL‐C) levels in chronic kidney disease populations remains unclear. This study evaluated the cardiovascular and renal outcomes in patients with stage 3 chronic kidney disease with different LDL‐C levels during statin treatment. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Chieh‐Li, Fan, Pei‐Chun, Lee, Cheng‐Chia, Chen, Jia‐Jin, Kuo, George, Tu, Yi‐Ran, Chu, Pao‐Hsien, Hsu, Hsiang‐Hao, Tian, Ya‐Chung, Chang, Chih‐Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673722/
https://www.ncbi.nlm.nih.gov/pubmed/36172933
http://dx.doi.org/10.1161/JAHA.122.027516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673722/
https://www.ncbi.nlm.nih.gov/pubmed/36172933
http://dx.doi.org/10.1161/JAHA.122.027516

Ejemplares similares